Yungjin Pharm. Market Cap

Yungjin Pharm. has a market cap or net worth of 373.1 billion as of November 17, 2025. Its market cap has decreased by -20.00% in one year.

Market Cap

373.10B

Enterprise Value

n/a

Revenue

158.79B

Ranking

n/a

PE Ratio

38.14

Stock Price

2,060.00

Market Cap Chart

Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 373.10B, an increase of 503.69%. That is a compound annual growth rate of 5.67%.

Market Cap History

Date	Market Cap	% Change
Nov 17, 2025	373.10B	2.62%
Dec 30, 2024	363.59B	-6.45%
Dec 28, 2023	388.65B	-34.62%
Dec 29, 2022	594.40B	-38.56%
Dec 30, 2021	967.50B	-34.20%
Dec 30, 2020	1.47T	21.27%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 30, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	86.90T
Celltrion	43.20T
ALTEOGEN	29.63T
SK Biopharmaceuticals	10.05T
ABL Bio	9.60T
Yuhan	9.35T
Peptron	7.22T
HLB Co., Ltd.	6.50T

Market Cap Rankings